Skip to main content

Find Clinical Trials

Home
Conditions
Meropenem

Clinical trial condition

Meropenem

Explore clinical trials studying Meropenem. Study availability and eligibility vary by location and protocol.

7 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Meropenem trial results

Recruiting

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

NCT06426836

Conditions: Amikacin, Amoxicillin-clavulanate, Cefazolin, +6 more
Locations: Queen Fabiola Children's University Hospital Brussels, Brussels Capital, Belgium

University Hospital Ghent, Belgium

Universitair hospital Leuven, Belgium

View Trial Details

Recruiting

Antibiotic Dosing in Pediatric Intensive Care

NCT02456974

Conditions: Amikacin, Amoxicillin-clavulanate, Ciprofloxacin, +5 more
Locations: Ghent University Hospital, Hospital Pharmacy Ghent, Belgium

View Trial Details

Not Yet Recruiting

Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children

NCT06929702

Conditions: Amoxicillin-clavulanate, Meropenem, Piperacillin-tazobactam
Locations: Ghent University Hospital Ghent, Belgium

View Trial Details

Completed

Empirical Meropenem Dosing in Critically Ill Patients: Early Assessment of Plasma Exposure and Minimum Inhibitory Concentration Targets

NCT07681544

Conditions: Critical Illness, Critically Ill, Disease Attributes, +5 more
Locations: Hospital Italiano de Buenos Aires Buenos Aires, Argentina

View Trial Details

Completed

Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis

NCT07113587

Conditions: Ampicillin, Aztreonam, Ciprofloxacin, +8 more
Locations: UK St. Pölten Sankt Pölten, Austria

View Trial Details

Completed

Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis

NCT07113574

Conditions: Anti-bacterial Agents, Antibacterial Agents, Aztreonam, +25 more
Locations: UK St. Pölten Sankt Pölten, Austria

View Trial Details

Completed

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

NCT03790631

Conditions: Amoxicillin, Beta-lactam Antibiotics, Cefepime, +8 more
Locations: Geneva University Hospitals Geneva, Canton of Geneva, Switzerland

View Trial Details